PMV Pharmaceuticals, Inc.PMVPNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank29
3Y CAGR-29.5%
5Y CAGR-36.3%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
-29.5%/yr
vs +37.5%/yr prior
5Y CAGR
-36.3%/yr
Recent acceleration
Acceleration
-67.0pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$37.98M-7.1%
2024$40.88M+8.4%
2023$37.71M-65.2%
2022$108.30M-37.2%
2021$172.47M-52.3%
2020$361.42M+393.2%
2019$73.28M+141.8%
2018$30.31M-